Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methadone maintenance and narcotic blocking drugs.

A Wikler

    The International Journal of the Addictions
    |October 1, 1977
    PubMed
    Summary

    Opioid antagonists like naloxone block opioid effects. This review covers key antagonists and their use in treatment programs for opioid-related conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of Morphine on Cortical Electrical Activity of the Rat.

    The Yale journal of biology and medicine·2011
    Same author

    Reactions of chronic totally decorticated dogs during a cycle of morphine addiction.

    Federation proceedings·2010
    Same author

    Effects of a cycle of morphine addiction on conditioned responses and experimental neuroses in dogs.

    Federation proceedings·2010
    Same author

    Effects of single doses of 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3) on the nervous system of dogs and cats.

    Federation proceedings·2010
    Same author

    Effect of single doses of 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3) on man.

    Federation proceedings·2010
    Same author

    Tolerance and physical dependence in intact and chronic spinal dogs during addiction to 10820 (4-4-diphenyl-6-dimethylamino-heptanone-3).

    Federation proceedings·2010

    Area of Science:

    • Pharmacology
    • Toxicology
    • Addiction Medicine

    Background:

    • Opioids are potent analgesics with significant abuse potential.
    • Opioid antagonists are crucial for managing overdose and addiction.
    • Understanding antagonist mechanisms is vital for clinical practice.

    Purpose of the Study:

    • To review drugs that specifically antagonize opioid actions.
    • To discuss various opioid antagonist compounds.
    • To explore programs utilizing antagonist treatment.

    Main Methods:

    • Literature review of opioid antagonists.
    • Analysis of pharmacological properties of antagonists.
    • Discussion of clinical applications and treatment programs.

    Main Results:

    • Identified key opioid antagonists: nalorphine, levallorphan, naloxone, naltrexone, and cyclazocine.
    • Detailed the specific actions antagonized by these drugs.
    • Highlighted the role of these antagonists in therapeutic interventions.

    Conclusions:

    • Opioid antagonists represent a critical class of drugs in managing opioid-related issues.
    • Naloxone, naltrexone, and others offer diverse therapeutic applications.
    • Further research into antagonist treatment programs is warranted.

    Related Experiment Videos